Protagonist Therapeutics (PTGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further p Read more

Investing in Biotech ETFs

04:56pm, Friday, 20'th Jan 2023 The Motley Fool

Here are the five best biotech ETFs to invest in right now. Read more

Should Schwab U.S. MidCap ETF (SCHM) Be on Your Investing Radar?

11:20am, Monday, 16'th Jan 2023 Zacks Investment Research

Style Box ETF report for SCHM Read more

Cramer Is Holding This Biotech Stock

02:16pm, Thursday, 12'th Jan 2023 Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN). When asked about Black Stone Minerals LP (NYSE: BSM), he said, "I like this situat Read more

BioMarin's Growth Prospects Soar with Potential Voxzogo and Roctavian Launches, Analyst Raises Price Target

07:49pm, Wednesday, 11'th Jan 2023 Benzinga

Wedbush has increased the price target on BioMarin Pharmaceutical Inc (NASDAQ: BMRN) from $74 to $84 while reiterating the Neutral rating. BioMarin reported three-year Phase 3 GENEr8-1 results f Read more

6 Analysts Have This to Say About Biomarin Pharmaceutical

06:00pm, Wednesday, 11'th Jan 2023 Benzinga

Biomarin Pharmaceutical (NASDAQ:BMRN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 1 0 0 Read more

2 Top Biotech Stocks Defying the Bear Market

05:43pm, Tuesday, 10'th Jan 2023 The Motley Fool

Some stocks are hitting new highs. Read more

BioMarin's (BMRN) Voxzogo Expanded Label Filing Accepted by EMA

04:10pm, Wednesday, 04'th Jan 2023 Zacks Investment Research

The EMA validates BioMarin's (BMRN) label expansion filing for Voxzogo to treat children under two years with achondroplasia. BMRN submits a filing for using Voxzogo in children under five years. Read more

Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen's favorites for 2023

12:57pm, Monday, 12'th Dec 2022 MarketWatch

Across the market, Cowen & Co. analysts see undervalued stocks. Read more

Why Is Horizon Therapeutics (HZNP) Up 38.3% Since Last Earnings Report?

04:31pm, Friday, 02'nd Dec 2022 Zacks Investment Research

Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more

Incyte (INCY) Up 3.3% Since Last Earnings Report: Can It Continue?

04:31pm, Thursday, 01'st Dec 2022 Zacks Investment Research

Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more

Expert Ratings for Biomarin Pharmaceutical

06:03pm, Tuesday, 29'th Nov 2022 Benzinga

Analysts have provided the following ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 5 Read more

Why Is BioMarin (BMRN) Up 14.1% Since Last Earnings Report?

04:31pm, Friday, 25'th Nov 2022 Zacks Investment Research

BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more

BioMarin (BMRN) Up After FDA Scraps AdCom Meet for BLA Filing

04:25pm, Thursday, 24'th Nov 2022 Zacks Investment Research

The FDA decides not to hold an advisory committee meeting for BioMarin Pharmaceuticals' (BMRN) regulatory filing seeking approval for hemophilia A gene therapy, valrox. Read more

Canceled AdCom, UniQure's Hemgenix Approval Show Positive Signs For BioMarin's Hemophilia Candidate

06:40pm, Wednesday, 23'rd Nov 2022 Benzinga

Earlier today, the FDA notified BioMarin Pharmaceutical Inc (NASDAQ: BMRN) that the agency no longer plans to hold an advisory committee meeting to discuss the Biologics License Application (BLA) Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by